Home > Media KIt > News Room

Unaudited Financial Results for the Quarter ended 31st December, 2009
Sr. No. Particulars Quarter ended  31.12.2009 (Unaudited) Quarter ended  31.12.2008 (Unaudited) 9 Months  ended  31.12.2009 (Unaudited) 9 Months  ended  31.12.2008 (Unaudited) Year ended 31.03.2009 (Audited)   
1(a) Net Sales 4182.28 4838.83 14115.93 13501.26 16510.22
(b) Other Operating Income 1.02 1.07 209.36 4.70 14.78
  Total (1a+1b) 4183.30 4839.90 14325.29 13505.96 16525.00
2 Expenditure          
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress (157.61) (82.34) (248.05) (18.29) (188.98)
  b)  Consumption of Raw Materials 2890.19 3740.51 10046.87 10209.58 11734.66
  c)  Employee Cost 555.63 475.06 1616.10 1383.04 1858.00
  d) Depreciation and Amortisation 1144.41 1175.85 3420.11 3527.57 4551.43
  e)  Other Expenditure 746.28 833.55 2181.57 2222.46 2829.37
  Total  5178.90 6142.63 17016.60 17324.36 20784.48
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2) (995.60) (1302.73) (2691.31) (3818.40) (4259.48)
4  Other Income                      -                       -                       -                       -                       -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4) (995.60) (1302.73) (2691.31) (3818.40) (4259.48)
6 Interest  93.92 39.95 180.67 137.05 201.12
7 Profit / (Loss) after Interest but before Exceptional Items (5-6) (1089.52) (1342.68) (2871.98) (3955.45) (4460.60)
8 Exceptional Items - Income/(Expense)                     -                       -                       -                       -                       -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8) (1089.52) (1342.68) (2871.98) (3955.45) (4460.60)
10 Tax Expense - Fringe Benefit Tax                     -   4.50                     -   15.03 28.06
11 Profit / (Loss) from Ordinary Activities after Tax (9-10) (1089.52) (1347.18) (2871.98) (3970.48) (4488.66)
12 Extraordinary Items-Income/(Expense)                     -                       -           3,385.77                     -   804.34
13 Net Profit /(Loss) for the period  (11-12) (1089.52) (1347.18) 513.79 (3970.48) (3684.32)
14 Paid-up Equity Share Capital (Face Value of Rs.2/- each) 8995.86 7146.06 8995.86 7146.06 7146.06
15 Reserves excluding Revaluation reserves                     -                       -                       -                       -   12346.39
16 a) Earning Per Share before Extraordinary Items (in Rs.)          
    - Basic & Diluted (0.24) (0.38) (0.71) (1.11) (1.26)
  b) Earning Per Share after Extraordinary Items (in Rs.)          
    - Basic & Diluted (0.24) (0.38) 0.13 (1.11) (1.03)
17 Public Shareholding          
    - Number of Shares 294454615 201964202 294454615 201964202 200805346
    -  Percentage of shareholding 65.46 56.52 65.46 56.52 56.20
18 Promoters and Promoter Group Shareholding          
  a) Pledged / Encumbered          
    - Number of Shares 610000 NA 610000 NA 1768856
    - Percentage of shares (as a % of the total shareholding of promoters and promoter group) 0.39 NA 0.39 NA 1.13
    - Percentage of shares (as a % of the total share capital of the company) 0.14 NA 0.14 NA 0.50
  b) Non-encumbered          
    - Number of Shares 154761588 NA 154761588 NA 154761588
    - Percentage of shares (as a % of the total shareholding of promoters and promoter group) 99.61 NA 99.61 NA 98.87
    - Percentage of shares (as a % of the total share capital of the company)              34.40 NA              34.40 NA 43.31

Notes:

  1. The above unaudited financial results were reviewed and recommended by the audit committee and approved by the Board of  Directors at their  meeting held on 21st January, 2010. A limited review of the same has been conducted by the Statutory Auditors.
  2. The Company is exclusively engaged in the Pharmaceuticals Business segment. Capital employed as on December 31st, 2009 is Rs. 56378.44 Lacs.
  3. Consolidated Income from Operations, Profit/(Loss) after tax and EPS (after extraordinary items) for the quarter ended 31st December, 2009 stands at Rs. 4904.71 Lacs, (Rs.1093.61) Lacs & (Rs.0.24) respectively.
  4. There were no investor complaints pending at the beginning of the quarter. During the quarter, three shareholder's complaints were received and resolved.
For and on behalf of the Board
Place: New Delhi
Date: 21.01.2010		 (Sushil Suri)
Chairman & Managing Director